Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/11/2014 | EP2739290A2 Method for selection of chemotherapeutic agents for adenocarcinoma cancer |
06/11/2014 | EP2739289A1 Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains |
06/11/2014 | EP2739288A2 Progesterone containing oral dosage forms and related methods |
06/11/2014 | EP2739287A1 Corticosteroids for the treatment of joint pain |
06/11/2014 | EP2739286A2 Bile acid recycling inhibitors for treatment of pancreatitis |
06/11/2014 | EP2739285A1 Selective inhibition of malt1 protease by phenothiazine derivatives |
06/11/2014 | EP2739284A1 Crizotinib for use in the treatment of cancer |
06/11/2014 | EP2739283A1 Polymorphic forms of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide |
06/11/2014 | EP2739282A1 New use of l-histidine and derivatives thereof |
06/11/2014 | EP2739281A1 Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance |
06/11/2014 | EP2739280A1 A method of managing chemotherapy induced alopecia or cachexia or both |
06/11/2014 | EP2739279A2 Novel aniline derivatives and use thereof |
06/11/2014 | EP2739278A1 Method for treating schizophrenia |
06/11/2014 | EP2739277A1 Treatment of type 2 diabetes with fty720 |
06/11/2014 | EP2739276A1 Antiseptic composition |
06/11/2014 | EP2739275A1 Antiseptic composition |
06/11/2014 | EP2739274A1 Treatment of cognitive impairment |
06/11/2014 | EP2739272A1 Process for preparing pharmaceutical compositions comprising fingolimod |
06/11/2014 | EP2739264A1 Pharmaceutical composition comprising ebastine and fluticasone |
06/11/2014 | EP2739262A2 Use of a cb1 receptor antagonist as a whitening and/or anti-browning agent for keratin material |
06/11/2014 | EP2739260A2 Use of cannabinoid compounds for stimulating melanogenesis |
06/11/2014 | EP2739154A1 Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates |
06/11/2014 | EP2739153A1 Treatment of breast cancer |
06/11/2014 | EP2739145A1 Subcutaneous needle assisted jet injection administration of methotrexate |
06/11/2014 | EP2739144A1 Compounds and therapeutic uses thereof |
06/11/2014 | EP2739139A1 Agonists of src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same |
06/11/2014 | CN203634513U 胶原蛋白口腔贴片 Collagen oral patch |
06/11/2014 | CN103857802A System for screening skin-whitening material |
06/11/2014 | CN103857702A Cationic peptidopolysaccharides with excellent broad- spectrum antimicrobial activities and high selectivity |
06/11/2014 | CN103857684A Novel phthalocyanine derivatives for therapeutic use |
06/11/2014 | CN103857683A Anti-viral compounds |
06/11/2014 | CN103857682A Azetidine derivatives for treatment of melanin related disorders |
06/11/2014 | CN103857681A Novel macrocycles as factor XIA inhibitors |
06/11/2014 | CN103857678A Pyrazoline derivatives and their use as selective androgen receptor modulators |
06/11/2014 | CN103857676A Pyrroloquinoline quinone alcohol adduct |
06/11/2014 | CN103857675A Metalloenzyme inhibitor compounds |
06/11/2014 | CN103857674A Aryl naphthalide lignans as anti-hiv agents |
06/11/2014 | CN103857672A Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
06/11/2014 | CN103857670A 2-oxo-piperidinyl derivatives |
06/11/2014 | CN103857669A Methods of producing anamorelin hydrochloride having controlled chloride content |
06/11/2014 | CN103857668A Ethynyl derivatives as mglur5 allosteric modulators |
06/11/2014 | CN103857659A Fused benzoxazepinones as ion channel modulators |
06/11/2014 | CN103857658A Ethynyl derivatives as metabotropic glutamate receptor modulators |
06/11/2014 | CN103857657A Heterocyclic derivative and pharmaceutical drug |
06/11/2014 | CN103857655A A compound for inhibiting 11ss-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same |
06/11/2014 | CN103857654A Compounds for targeting drug delivery and enhancing siRNA activity |
06/11/2014 | CN103857404A Agent for improving quality of sleep |
06/11/2014 | CN103857403A Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds |
06/11/2014 | CN103857400A Rhodiola rosea extracts and isolated compounds and uses thereof for treating neurodegenerative diseases |
06/11/2014 | CN103857399A New natural and synthetic compounds for treating cancer and other diseases |
06/11/2014 | CN103857398A Treatment of rhinitis |
06/11/2014 | CN103857397A Noribogaine salt ansolvates |
06/11/2014 | CN103857396A Inhibitors of bruton's tyrosine kinase |
06/11/2014 | CN103857395A Combinations of AKT inhibitor compounds and abiraterone, and methods of use |
06/11/2014 | CN103857394A Therapeutic uses of ectoin |
06/11/2014 | CN103857393A Cyclopropylamines as LSD1 inhibitors |
06/11/2014 | CN103857392A 2 - carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases |
06/11/2014 | CN103857390A Process for manufacturing hmb and salts thereof |
06/11/2014 | CN103857389A Rasagiline citramide |
06/11/2014 | CN103857388A Compositions comprising salbutamol sulphate |
06/11/2014 | CN103857386A Tamper-resistant tablet providing immediate drug release |
06/11/2014 | CN103857384A Method for the synthesis of porphyrin-phospholipid conjugates |
06/11/2014 | CN103857288A Amino-quinolines as kinase inhibitors |
06/11/2014 | CN103849527A Medicinal liquor capable of tonifying lung and keeping young |
06/11/2014 | CN103848986A New compound containing cephalosporin structure as well as preparation method and application thereof |
06/11/2014 | CN103848985A Novel compound containing sunitinib analogue structure as well as preparation method and application thereof |
06/11/2014 | CN103848921A Lyceum ruthenicum alkali-extracted polysaccharide and preparation method and application thereof |
06/11/2014 | CN103848919A Preparation method of antioxidant active isatis root polysaccharide |
06/11/2014 | CN103848881A Two new compounds in ophiopogon japonicus, preparation method and medicinal purposes |
06/11/2014 | CN103848878A Method for extracting N6-(2-ethoxyl) adenosine from cordyceps militaris and application of N6-(2-ethoxyl) adenosine |
06/11/2014 | CN103848876A Nucleoside phosphamide prodrug as well as preparation method and application of nucleoside phosphamide prodrug |
06/11/2014 | CN103848875A Preparation method of gentiopicroside raw material |
06/11/2014 | CN103848856A Camptothecin derivative with antineoplastic activity |
06/11/2014 | CN103848852A New compound containing cephalosporin structure as well as preparation method and application thereof |
06/11/2014 | CN103848845A Prasugrel sesquihydrate and preparation method thereof |
06/11/2014 | CN103848844A Prasugrel salt-forming compound and preparation method thereof |
06/11/2014 | CN103848840A Camptothecin derivatives and medical application thereof |
06/11/2014 | CN103848838A c-Met-VEGFR-2 double antagonist, preparation method and medical use thereof |
06/11/2014 | CN103848837A Compound for reducing intraocular pressure and application thereof |
06/11/2014 | CN103848836A Ticagrelor sesquihydrate and preparation method thereof |
06/11/2014 | CN103848835A Dipeptidyl peptidase-IV inhibitor, application thereof, intermediate body thereof and preparation method of intermediate body thereof |
06/11/2014 | CN103848833A Pyrrolotriazines derivative, its preparation method and application of pyrrolotriazines derivative on medicine |
06/11/2014 | CN103848831A Doxofylline compound and pharmaceutical composition thereof |
06/11/2014 | CN103848829A Heteroaryl alkyne compounds and application thereof |
06/11/2014 | CN103848828A Application of oxadiazole derivatives in anti-cancer drugs |
06/11/2014 | CN103848827A Application of benzotriazole derivatives in anti-cancer drugs |
06/11/2014 | CN103848825A Preparation method and application of sulfonium sugar natural product with inhibition activity on alpha-glucosidase and derivatives thereof |
06/11/2014 | CN103848823A Compound for treating neurodegenerative diseases and application thereof |
06/11/2014 | CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition |
06/11/2014 | CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs |
06/11/2014 | CN103848819A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition in drugs |
06/11/2014 | CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs |
06/11/2014 | CN103848814A Substituted indole ketone derivative as tyrosine kinase inhibitor |
06/11/2014 | CN103848811A Uracil derivative, preparation method and application thereof |
06/11/2014 | CN103848810A Bruton's tyrosine kinases inhibitor |
06/11/2014 | CN103848809A Dibenzocyclooctene lignans, microbial conversion products thereof and applications of the microbial conversion products |
06/11/2014 | CN103848806A Glucopyranosyl derivative as well as preparation method and application thereof in medicines |
06/11/2014 | CN103848805A Compound for treating neurodegenerative diseases and application thereof |
06/11/2014 | CN103848798A 2-Arylselenazole compounds and medicinal composition thereof |
06/11/2014 | CN103848796A Deuterium-substituted 2-phenylthiazole compound, and pharmaceutical composition thereof |